8-K
filed August 6, 2024, 7:59 PM ET
ticker AHCO
CIK 0001725255
earnings
confidence high
sentiment neutral
materiality 0.60
AdaptHealth Q2 revenue $806M (+1.6% YoY); net income $19.4M; narrows guidance
AdaptHealth Corp.
2024-Q2 EPS reported
$0.12
revenue$1,598,472,000
- Net revenue $806.0M vs $793.3M YoY; net income $19.4M (+39%); adjusted EBITDA $165.3M (-3.3%).
- Year-to-date operating cash flow $247.0M (+$20.4M YoY); free cash flow $77.9M (+$23.1M).
- Signed definitive agreement to divest certain non-core assets; closing expected Q3 2024.
- FY2024 guidance: net revenue $3.255-3.315B, adj. EBITDA $660-700M, free cash flow $160-180M.
- CEO Suzanne Foster noted results in line with expectations; optimistic about unified team effort.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001628280-24-034954
- form_type
- 8-K
- ticker
- AHCO
- cik
- 0001725255
- company_name
- AdaptHealth Corp.
- filed_at
- 2024-08-06T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:14.287310+00:00
- generated_at
- 2026-05-31T12:21:05.047019+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001628280-24-034954
- json_url
- https://secwatch.observer/filing/0001628280-24-034954.json
- markdown_url
- https://secwatch.observer/filing/0001628280-24-034954.md
- text_url
- https://secwatch.observer/filing/0001628280-24-034954.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1725255/000162828024034954/0001628280-24-034954-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1725255/000162828024034954/ahco-20240806.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
IVF
INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M
INVO Fertility, Inc.
June 2, 2026, 8:40 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
POLA
Polar Power Q1 net loss narrows 86% to $178K; gross margin expands to 65.7%
Polar Power, Inc.
June 2, 2026, 8:30 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
CTRN
Citi Trends Q1 sales up 14.4% to $230.9M; adjusted EBITDA doubles to $13.9M
Citi Trends Inc
June 2, 2026, 6:58 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DAVEY TREE EXPERT CO
Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M
DAVEY TREE EXPERT CO
June 1, 2026, 1:50 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
BKE
Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M
BUCKLE INC
May 29, 2026, 3:38 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
HIND
Vyome Q1 net loss $963K, cash $8.8M, inks JAK inhibitor licensing deal with Impetis
Vyome Holdings, Inc
May 29, 2026, 8:42 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
PKE
Park Aerospace Q4 sales up 43% to $24.2M; EPS $0.19 vs $0.06 YoY; full-year net earnings double to $11.3M
PARK AEROSPACE CORP
May 28, 2026, 4:29 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
GAP
Gap Inc. Q1 net sales up 1% to $3.5B; adj. EPS $0.38; raises full-year EPS outlook
GAP INC
May 28, 2026, 4:16 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.